VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ITGR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ITGRInteger Holdings Corporation
$91.90$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

ITGR logoInteger Holdings Corporation(ITGR)Earnings, Financials & Key Ratios

ITGR•NYSE
$91.90
31.8× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDevice suppliers, distribution, and services
AboutInteger Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.Show more
  • Revenue$1.85B+7.6%
  • EBITDA$335M+5.4%
  • Net Income$103M-14.3%
  • EPS (Diluted)2.89-15.0%
  • Gross Margin23.06%-14.2%
  • EBITDA Margin18.15%-2.0%
  • Operating Margin11.33%-6.6%
  • Net Margin5.57%-20.3%
  • ROE6.11%-20.1%

ITGR Price & Volume

Integer Holdings Corporation (ITGR) stock price & volume — 10-year historical chart

Loading chart...

Stagnant Growth and Margin Compression Cloud Outlook

Investment Thesis • Updated 2026Q1

VerdictNegative: The company's inability to scale profitability is highlighted by a 3.8% net margin and a high P/FCF multiple of 30.73
Growth:Decelerating
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Margin compression and volatility

Key Thesis Takeaways

  • Integer Holdings faces a challenging fundamental outlook characterized by decelerating revenue growth, which fell to 0.8% in 2026Q1, and persistent margin erosion as gross margins compressed to 24.9%.
  • The company's reliance on an acquisition-heavy strategy is evidenced by $1.1B in goodwill, representing 32% of total assets, while high financial leverage with $1.4B in total debt limits operational flexibility.
  • Investors should monitor the sustainability of the current business model, as the company struggles to achieve consistent operating leverage and maintains a fragile net margin of 3.8%.

Verdict Logic

suggesting the current valuation does not adequately reflect the underlying operational risks.

ITGR Growth Metrics

Integer Holdings Corporation (ITGR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.72%
5 Years11.46%
3 Years11.52%
TTM6.01%

Profit CAGR

10 Years-
5 Years5.87%
3 Years15.68%
TTM84.5%

EPS CAGR

10 Years-
5 Years4.4%
3 Years13.82%
TTM90.05%

Return on Capital

10 Years5.84%
5 Years6.19%
3 Years6.86%
Last Year6.94%

ITGR Recent Earnings

Integer Holdings Corporation (ITGR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026
Metric
Actual
Est
EPS
$1.20-0.8%
$1.21
Rev
$440M+3.1%
$426M
Q1 2026
Feb 19, 2026
Metric
Actual
Est
EPS
$1.76+3.5%
$1.70
Rev
$472M+2.0%
$463M
Q4 2025
Oct 23, 2025
Metric
Actual
Est
EPS
$1.79+6.5%
$1.68
Rev
$468M+1.1%
$463M
Q3 2025
Jul 24, 2025
Metric
Actual
Est
EPS
$1.55-1.3%
$1.57
Rev
$476M+2.2%
$466M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$1.20vs $1.21-0.8%
$440Mvs $426M+3.1%
Q1 2026Feb 19, 2026
$1.76vs $1.70+3.5%
$472Mvs $463M+2.0%
Q4 2025Oct 23, 2025
$1.79vs $1.68+6.5%
$468Mvs $463M+1.1%
Q3 2025Jul 24, 2025
$1.55vs $1.57-1.3%
$476Mvs $466M+2.2%
Based on last 12 quarters of dataView full earnings history →

Latest ITGR News

Recent stock market news and headlines for Integer Holdings Corporation (ITGR)

GlobeNewsWire·6 days ago
Integer Announces Conference Call to Discuss Second Quarter 2026 Results

PLANO, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today that it will webcast its conference call to discuss financial results and business highlights for the second quarter ended July 3, 2026, on Thursday, Aug. 6, 2026, at 8 a.m. CT (9 a.m. ET). Other forward-looking and material information may also be discussed during the call.

Peers Comparison

Key metrics vs top competitors for Integer Holdings Corporation (ITGR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ITGR logoITGRInteger Holdings CorporationCurrent
$91.90$3.16B31.807.57%5.57%6.11%—
NVCR logoNVCRNovoCure Limited
$17.72$2.02B-14.528.28%-25.66%-50.82%—
LIVN logoLIVNLivaNova PLC
$83.58$4.59B-18.7810.74%7.47%9.13%—
ANIK logoANIKAnika Therapeutics, Inc.
$15.87$212.67M-20.88-5.91%-9.52%-7.74%—
LAKE logoLAKELakeland Industries, Inc.
$11.84$116.85M-4.5015.21%-10.88%-15.54%—
ATRC logoATRCAtriCure, Inc.
$32.80$1.66B-136.6714.88%-0.83%-0.95%—

Compare ITGR vs Peers

Integer Holdings Corporation (ITGR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for ITGR.

Scale Benchmark

vs APH

Larger-name benchmark to compare ITGR against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, LIVN, ANIK, LAKE

ITGR SEC Filings & Documents

Integer Holdings Corporation (ITGR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 12, 2026·SEC

Material company update

Feb 19, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 23, 2026·SEC

FY 2025

Feb 20, 2025·SEC

FY 2024

Feb 20, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 23, 2025·SEC

FY 2025

Jul 24, 2025·SEC

Get notified when ITGR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ITGR Frequently Asked Questions

Integer Holdings Corporation (ITGR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Integer Holdings Corporation's revenue?

Integer Holdings Corporation (ITGR) reported $1.85B in revenue for fiscal year 2025. This represents a 2235% increase from $79.2M in 1999.

How fast is Integer Holdings Corporation growing?

Integer Holdings Corporation (ITGR) grew revenue by 7.6% over the past year. This is steady growth.

Is ITGR profitable?

Yes, Integer Holdings Corporation (ITGR) is profitable, generating $141.8M in net income for fiscal year 2025 (5.6% net margin).

Dividend & Returns
What is ITGR's return on equity?

Integer Holdings Corporation (ITGR) has a return on equity (ROE) of 6.1%. This is below average, suggesting room for improvement.

What is Integer Holdings Corporation's free cash flow?

Integer Holdings Corporation (ITGR) generated $168.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ITGR back in 1999?

Total return calculator · dividends reinvested · 27+ years of data

See returns →